VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jack w garnes jr. who wrote (7846)	5/6/1998 2:14:00 PM
From: Gene Voss	Read Replies (2) of 23519

RE: ZONA: Phentolamine is readily available,and any compounding pharmacist can get you some.Their story shows the lack of knowledge controlling the ED market.If they ever recieve approval I or anyone else can file a 510K and manufacture an identical product without fear of recourse since no patented technology protects them. The main problem of course is that phentolamine is dangerous and ineffective.A gigantic gulf exists between the facts and the knowledge exhibited by investors in this area.The assumption that all these competing oral agents will control some part of the ED market assumes these agents work.In the case of phentolamine this is absurd. GV

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next